Results 41 to 47 of about 28,811 (47)

Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study.

European Heart Journal, 2020
AIMS In a randomized, parallel, blinded study, we investigate the impact of clopidogrel, prasugrel, or ticagrelor on peripheral endothelial function in patients undergoing stenting for an acute coronary syndrome.
B. Schnorbus, A. Daiber, K. Jurk, S. Warnke, J. Koenig, K. Lackner, T. Münzel, T. Gori   +7 more
semanticscholar   +1 more source

Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization

Circulation, 2018
Background: Elderly patients are at elevated risk of both ischemic and bleeding complications after an acute coronary syndrome and display higher on-clopidogrel platelet reactivity compared with younger patients.
S. Savonitto, Luca A. Ferri, L. Piatti, D. Grosseto, G. Piovaccari, N. Morici, I. Bossi, P. Sganzerla, G. Tortorella, M. Cacucci, M. Ferrario, E. Murena, G. Sibilio, S. Tondi, A. Toso, S. Bongioanni, A. Ravera, E. Corrada, M. Mariani, L. Di Ascenzo, A. Petronio, C. Cavallini, G. Vitrella, R. Rogacka, R. Antonicelli, B. Cesana, L. De Luca, F. Ottani, G. De Luca, F. Piscione, N. Moffa, S. de Servi, L. Bolognese, F. Bovenzi, G. Steffenino, I. Santilli, G. Bassanelli, A. Sacco, F. Canziani, Marco Ferri, Emilia Lo Jacono, U. Canosi, G. Fornaro, M. Leoncini, Maria Rosa Conte, R. Farina, C. Stefanin, F. di Pede, P. Chella, M. Chiara Nardoni, P. Tamburrini, B. Trimarco, G. Galasso, R. Elia, S. Grotti, L. Borrelli, C. Tamburino, P. Capranzano, B. Francaviglia, C. Campana, R. Bonatti, Alessandro Martinoni, Fabio Abate, S. Coscarelli, P. Rubartelli, Giovanni Q. Villani, R. Rossini   +66 more
semanticscholar   +1 more source

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

The Lancet, 1996
D. Schultz
semanticscholar   +1 more source

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

The Lancet, 2013
W. Dewilde, T. Oirbans, F. Verheugt, J. Kelder, B. Smet, J. Herrman, T. Adriaenssens, M. Vrolix, A. Heestermans, M. Vis, Jan GP Tijsen, A. Hof, J. Berg   +12 more
semanticscholar   +1 more source

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

The Lancet, 2004
H. Diener, J. Bogousslavsky, L. Brass, C. Cimminiello, L. Csiba, M. Kaste, D. Leys, J. Matías-Guiu, H. Rupprecht   +8 more
semanticscholar   +1 more source

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Lancet, 2006
S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, S. Yusuf   +6 more
semanticscholar   +1 more source

Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial

The Lancet, 2005
Zhengming Chen, Lixin Jiang, Yiping Chen, J. Xie, H. Pan, R. Peto, R. Collins, Lisheng Liu, Commit   +8 more
semanticscholar   +1 more source